Work

Spectrum: Phase II Study of Tislelizumab Plus Pemetrexed in Patients with Relapsed or Refractory (R/R) Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): The Korean Cancer Study Group LY22-07

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-202877

Authors: Tae Min Kim, Jung Sun Kim, Gyeong-Won Lee, Myung-Won Lee, Jeonghwan Youk, Hyun Jung Lee, Sung-Nam Lim, Soyeon Kim, Yoon Kyung Jeon, Chul-Kee Park, Dae Seog Heo

Institutions: Seoul National University, Seoul National University Hospital, Gyeongsang National University, Gyeongsang National University Hospital, Chungnam National University, Inje University Haeundae Paik Hospital

Language: English

Topic: CNS Lymphoma Diagnosis and Treatment

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405038503

Cites:

Cited by: 1

Related to: 10